OnKure Therapeutics, Inc. (OKUR)
OnKure Therapeutics, Inc. (OKUR) Insider Trading
Directors, officers and holders of more than 10% of OKUR report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 109 transactions on file: 0 with code P, 4 with code S and 46 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Saccomano Nicholas A | President and CEO | S Sale | 87 | $2.97 | $259 |
| Sep 21, 2026 | Leverone Jason A. | Chief Financial Officer | S Sale | 302 | $2.97 | $898 |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | A Award | 542,232 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | D Disposition | 8,449 | Not measured | Not measured |
| Aug 7, 2026 | Carruthers R Michael | Director | A Award | 22,350 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | D Disposition | 2,359 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | A Award | 16,898 | Not measured | Not measured |
| Aug 7, 2026 | Leverone Jason A. | Chief Financial Officer | A Award | 5,322 | Not measured | Not measured |
| Aug 7, 2026 | Agresta Samuel | Chief Medical Officer | A Award | 18,588 | Not measured | Not measured |
| Aug 7, 2026 | Leverone Jason A. | Chief Financial Officer | D Disposition | 5,322 | Not measured | Not measured |
| Aug 7, 2026 | Hartley Dylan | Chief Scientific Officer | A Award | 137,603 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | D Disposition | 16,898 | Not measured | Not measured |
| Aug 7, 2026 | Mathers Edward T | Director | A Award | 22,350 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | D Disposition | 1,485 | Not measured | Not measured |
| Aug 7, 2026 | Agresta Samuel | Chief Medical Officer | D Disposition | 18,588 | Not measured | Not measured |
| Aug 7, 2026 | Leverone Jason A. | Chief Financial Officer | D Disposition | 130,611 | Not measured | Not measured |
| Aug 7, 2026 | Agresta Samuel | Chief Medical Officer | D Disposition | 131,396 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | D Disposition | 542,232 | Not measured | Not measured |
| Aug 7, 2026 | Manke Isaac | Director | A Award | 300,000 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | A Award | 2,359 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | A Award | 1,485 | Not measured | Not measured |
| Aug 7, 2026 | Leverone Jason A. | Chief Financial Officer | D Disposition | 5,781 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | A Award | 8,449 | Not measured | Not measured |
| Aug 7, 2026 | Leverone Jason A. | Chief Financial Officer | A Award | 5,781 | Not measured | Not measured |
| Aug 7, 2026 | Hartley Dylan | Chief Scientific Officer | D Disposition | 137,603 | Not measured | Not measured |
| Aug 7, 2026 | Leverone Jason A. | Chief Financial Officer | A Award | 130,611 | Not measured | Not measured |
| Aug 7, 2026 | Saccomano Nicholas A | President and CEO | A Award | 150,000 | Not measured | Not measured |
| Aug 7, 2026 | GREY MICHAEL G | Director | A Award | 22,350 | Not measured | Not measured |
| Aug 7, 2026 | Leverone Jason A. | Chief Financial Officer | A Award | 50,000 | Not measured | Not measured |
| Aug 7, 2026 | Agresta Samuel | Chief Medical Officer | A Award | 131,396 | Not measured | Not measured |
| Aug 7, 2026 | Phillips Andrew John | Director | A Award | 22,350 | Not measured | Not measured |
| Aug 7, 2026 | Manke Isaac | Director | A Award | 15,300 | Not measured | Not measured |
| Aug 7, 2026 | Hartley Dylan | Chief Scientific Officer | A Award | 50,000 | Not measured | Not measured |
| Aug 7, 2026 | Ratcliffe Liam | Director | A Award | 22,350 | Not measured | Not measured |
| Aug 7, 2026 | Agresta Samuel | Chief Medical Officer | A Award | 50,000 | Not measured | Not measured |
| Aug 7, 2026 | Manke Isaac | Director | D Disposition | 15,300 | Not measured | Not measured |
| Aug 7, 2026 | Jansen Valerie Malyvanh | Director | A Award | 22,350 | Not measured | Not measured |
| Jun 22, 2026 | Saccomano Nicholas A | President and CEO | S Sale | 86 | $4.40 | $378 |
| Jun 22, 2026 | Leverone Jason A. | Chief Financial Officer | S Sale | 303 | $4.40 | $1,332 |
| Jun 4, 2026 | Carruthers R Michael | Director | A Award | 7,650 | Not measured | Not measured |
| Jun 4, 2026 | GREY MICHAEL G | Director | A Award | 7,650 | Not measured | Not measured |
| Jun 4, 2026 | Mathers Edward T | Director | A Award | 7,650 | Not measured | Not measured |
| Jun 4, 2026 | Jansen Valerie Malyvanh | Director | A Award | 7,650 | Not measured | Not measured |
| Jun 4, 2026 | Phillips Andrew John | Director | A Award | 7,650 | Not measured | Not measured |
| Jun 4, 2026 | Ratcliffe Liam | Director | A Award | 1,275 | Not measured | Not measured |
| Apr 1, 2026 | Leverone Jason A. | Chief Financial Officer | A Award | 110,000 | Not measured | Not measured |
| Apr 1, 2026 | Agresta Samuel | Chief Medical Officer | A Award | 110,000 | Not measured | Not measured |
| Apr 1, 2026 | Saccomano Nicholas A | President and CEO | A Award | 330,000 | Not measured | Not measured |
| Apr 1, 2026 | Hartley Dylan | Chief Scientific Officer | A Award | 110,000 | Not measured | Not measured |
| Mar 31, 2026 | Ratcliffe Liam | Director | A Award | 15,300 | Not measured | Not measured |
The full Form 4 history is on the OKUR company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.